Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 209

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9C
Chunk 209
---
Audit
Committee

We
have established an audit committee (“Audit Committee”), which consists of three independent directors: Holger Weis, Allison
W. Brady and Nicholas Hemmerly. Mr. Weis is the chair of the Audit Committee. Mr. Weis qualifies as an audit committee financial expert
under SEC rules and as a financially sophisticated audit committee member under the Nasdaq Capital Market rules. Our Audit Committee
operates under a written charter that is reviewed annually. A copy of the charter is posted on the Corporate Governance
section of our website, at www.jupiterneurosciences.com.

Our
Audit Committee is authorized to:

    ●
    approve
    and retain the independent auditors to conduct the annual audit of our financial statements;

    ●
    review
    the proposed scope and results of the audit;

    ●
    review
    and pre-approve audit and non-audit fees and services;

    ●
    review
    accounting and financial controls with the independent auditors and our financial and accounting staff;

    ●
    review
    and approve transactions between us and our directors, officers and affiliates;

    ●
    recognize
    and prevent prohibited non-audit services;

    ●
    establish
    procedures for complaints received by us regarding accounting matters; and

    ●
    oversee
    internal audit functions, if any.

Compensation
Committee

We
have established a compensation committee (“Compensation Committee”), which consists of three independent directors: Nicholas
H. Hemmerly, Julie Kampf and Allison Brady. Mr. Hemmerly is the chair of the Compensation Committee. Our Compensation Committee operates
under a written charter that is reviewed annually.7 A copy of the charter is posted on the Corporate Governance section
of our website, at www.jupiterneurosciences.com.

The
Compensation Committee is authorized to:

    ●
    review
    and determine the compensation arrangements for management;

    ●
    establish
    and review general compensation policies with the objective to attract and retain superior talent, to reward individual performance
    and to achieve our financial goals;

    ●
    administer
    our incentive compensation and benefit plans and purchase plans;

    ●
    oversee
    the evaluation of the Board of Directors and management; and

    ●
    review
    the independence of any compensation advisers.

Nominating
and Corporate Governance Committee

We
have established a nominating and corporate governance committee (“Nominating and Corporate Governance Committee